Christian Camani

Christian Camani is an experienced investor actively involved in multiple companies, including Turn2X since March 2023, Veesion, ONWARD, and PathoQuest, all of which Christian joined in 2022 and 2021, respectively. Christian has been investing in Threatray since January 2021, Attolight since December 2017, AVAtronics and Biograil™ since March and February 2020, respectively, and in Wildbiene + Partner and InterAx Biotech since January 2019. Christian holds a Master of Business Administration (MBA) degree from the University of St.Gallen, obtained between 1987 and 1992.